NO20074303L - 7-{4-[2-(2,6-diklor-4-metylfenoksy)etoksy]fenyl}-3,9-diazabisyklo-[3.3.1]non-6-en-6-karboksylsyresyklopropyl-(2,3-dimetylbenzyl)amid som renininhibitor til behandling av hypertensjon - Google Patents
7-{4-[2-(2,6-diklor-4-metylfenoksy)etoksy]fenyl}-3,9-diazabisyklo-[3.3.1]non-6-en-6-karboksylsyresyklopropyl-(2,3-dimetylbenzyl)amid som renininhibitor til behandling av hypertensjonInfo
- Publication number
- NO20074303L NO20074303L NO20074303A NO20074303A NO20074303L NO 20074303 L NO20074303 L NO 20074303L NO 20074303 A NO20074303 A NO 20074303A NO 20074303 A NO20074303 A NO 20074303A NO 20074303 L NO20074303 L NO 20074303L
- Authority
- NO
- Norway
- Prior art keywords
- diazabicyclo
- karboksylsyresyklopropyl
- methylphenoxy
- dimethylbenzyl
- ene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/504—Pyridazines; Hydrogenated pyridazines forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP2005000842 | 2005-01-28 | ||
PCT/IB2006/050285 WO2006079988A1 (fr) | 2005-01-28 | 2006-01-26 | Acide 7-{4-[2-(2,6-dichloro-4-methylphenoxy)ethoxy]phenyl}-3,9-diazabicyclo[3.3.31]non-6-ene-6-carboxylique cyclopropyl-(2,3-dimethylbenzyl)amide utilises comme inhibiteurs de la renine pour le traitement de l'hypertension |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20074303L true NO20074303L (no) | 2007-08-22 |
Family
ID=36263952
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20074303A NO20074303L (no) | 2005-01-28 | 2007-08-22 | 7-{4-[2-(2,6-diklor-4-metylfenoksy)etoksy]fenyl}-3,9-diazabisyklo-[3.3.1]non-6-en-6-karboksylsyresyklopropyl-(2,3-dimetylbenzyl)amid som renininhibitor til behandling av hypertensjon |
Country Status (20)
Country | Link |
---|---|
US (1) | US7915259B2 (fr) |
EP (1) | EP1846407B1 (fr) |
JP (1) | JP4111533B1 (fr) |
KR (1) | KR100938364B1 (fr) |
CN (1) | CN101107248A (fr) |
AR (1) | AR052894A1 (fr) |
AT (1) | ATE514697T1 (fr) |
AU (1) | AU2006208992A1 (fr) |
CA (1) | CA2595986A1 (fr) |
CR (1) | CR9268A (fr) |
ES (1) | ES2367267T3 (fr) |
IL (1) | IL184885A0 (fr) |
MA (1) | MA29267B1 (fr) |
MX (1) | MX2007009004A (fr) |
NI (1) | NI200700189A (fr) |
NO (1) | NO20074303L (fr) |
RU (1) | RU2007132438A (fr) |
TW (1) | TW200637861A (fr) |
WO (1) | WO2006079988A1 (fr) |
ZA (1) | ZA200705752B (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1786814B1 (fr) * | 2004-08-25 | 2010-03-31 | Actelion Pharmaceuticals Ltd. | Dérivés du bicyclononène employés en tant qu'inhibiteurs de la rénine |
RU2410374C2 (ru) * | 2005-05-27 | 2011-01-27 | Актелион Фармасьютикалз Лтд | Новые амидные производные пиперидинкарбоновой кислоты |
WO2007088514A1 (fr) * | 2006-02-02 | 2007-08-09 | Actelion Pharmaceuticals Ltd | Amines secondaires en tant qu'inhibiteurs de la rénine |
US20090062342A1 (en) * | 2006-03-08 | 2009-03-05 | Actelion Pharmaceuticals Ltd. | Amines |
CL2007002689A1 (es) * | 2006-09-18 | 2008-04-18 | Vitae Pharmaceuticals Inc | Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras. |
WO2008088690A2 (fr) * | 2007-01-12 | 2008-07-24 | Merck & Co., Inc. | Procédé de préparation de composés diazabicyclo[3.3.1]nonane |
US8129538B1 (en) | 2007-03-28 | 2012-03-06 | Takeda Pharmaceutical Company Limited | Renin inhibitors |
US8343968B2 (en) | 2007-05-24 | 2013-01-01 | Merck Canada Inc. | Case of renin inhibitors |
US8334308B2 (en) | 2007-08-20 | 2012-12-18 | Merck Sharp & Dohme Corp. | Renin inhibitors |
BRPI0912388A2 (pt) | 2008-05-05 | 2017-09-26 | Merck Frosst Canada Ltd | composto, forma cristalina, processo para preparar compostos, composição farmacêutica, e, uso de um composto, e, método para o tratamento ou profilaxia de doenças |
EP3060560A1 (fr) | 2013-10-25 | 2016-08-31 | Blueprint Medicines Corporation | Inhibiteurs du récepteur du facteur de croissance des fibroblastes |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0863875T3 (da) | 1995-09-07 | 2003-12-01 | Hoffmann La Roche | Hidtil ukendte 4-(oxyalkoxyphenyl)-3-oxy-piperiner til behandling af hjerte- og nyrelidelser |
JP4041123B2 (ja) | 2002-04-29 | 2008-01-30 | アクテリオン ファマシューティカルズ リミテッド | 新規なジアザビシクロノネン |
US20060217371A1 (en) | 2003-04-28 | 2006-09-28 | Olivier Bezencon | Diazabicyclononene and tetrahydropyriddine derivatives as renin inhibitors |
US20060223795A1 (en) | 2003-05-02 | 2006-10-05 | Oliver Bezencon | Novel diazabicyclononene derivatives |
BRPI0409882A (pt) | 2003-05-02 | 2006-05-23 | Actelion Pharmaceuticals Ltd | compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos |
WO2004105762A1 (fr) | 2003-05-30 | 2004-12-09 | Actelion Pharmaceuticals Ltd | Utilisation medicale de derives de diazabicyclononene utilises comme inhibiteurs des proteases aspartiques parasites |
-
2006
- 2006-01-26 WO PCT/IB2006/050285 patent/WO2006079988A1/fr active Application Filing
- 2006-01-26 JP JP2007551803A patent/JP4111533B1/ja not_active Expired - Fee Related
- 2006-01-26 RU RU2007132438/04A patent/RU2007132438A/ru not_active Application Discontinuation
- 2006-01-26 ES ES06710758T patent/ES2367267T3/es active Active
- 2006-01-26 CN CNA2006800027614A patent/CN101107248A/zh active Pending
- 2006-01-26 AU AU2006208992A patent/AU2006208992A1/en not_active Abandoned
- 2006-01-26 CA CA002595986A patent/CA2595986A1/fr not_active Abandoned
- 2006-01-26 EP EP06710758A patent/EP1846407B1/fr active Active
- 2006-01-26 US US11/795,850 patent/US7915259B2/en not_active Expired - Fee Related
- 2006-01-26 MX MX2007009004A patent/MX2007009004A/es not_active Application Discontinuation
- 2006-01-26 AT AT06710758T patent/ATE514697T1/de not_active IP Right Cessation
- 2006-01-26 KR KR1020077019567A patent/KR100938364B1/ko not_active IP Right Cessation
- 2006-01-27 TW TW095103557A patent/TW200637861A/zh unknown
- 2006-01-27 AR ARP060100313A patent/AR052894A1/es not_active Application Discontinuation
-
2007
- 2007-07-12 ZA ZA200705752A patent/ZA200705752B/xx unknown
- 2007-07-20 CR CR9268A patent/CR9268A/es not_active Application Discontinuation
- 2007-07-26 IL IL184885A patent/IL184885A0/en unknown
- 2007-07-27 NI NI200700189A patent/NI200700189A/es unknown
- 2007-08-22 NO NO20074303A patent/NO20074303L/no not_active Application Discontinuation
- 2007-08-24 MA MA30163A patent/MA29267B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
IL184885A0 (en) | 2007-12-03 |
ZA200705752B (en) | 2009-02-25 |
AR052894A1 (es) | 2007-04-11 |
CA2595986A1 (fr) | 2006-08-03 |
US20080161313A1 (en) | 2008-07-03 |
AU2006208992A1 (en) | 2006-08-03 |
MX2007009004A (es) | 2007-09-14 |
MA29267B1 (fr) | 2008-02-01 |
KR100938364B1 (ko) | 2010-01-22 |
EP1846407A1 (fr) | 2007-10-24 |
JP2008528478A (ja) | 2008-07-31 |
CN101107248A (zh) | 2008-01-16 |
KR20080001707A (ko) | 2008-01-03 |
CR9268A (es) | 2007-10-23 |
TW200637861A (en) | 2006-11-01 |
ATE514697T1 (de) | 2011-07-15 |
JP4111533B1 (ja) | 2008-07-02 |
EP1846407B1 (fr) | 2011-06-29 |
RU2007132438A (ru) | 2009-03-10 |
ES2367267T3 (es) | 2011-10-31 |
NI200700189A (es) | 2008-04-24 |
US7915259B2 (en) | 2011-03-29 |
WO2006079988A1 (fr) | 2006-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20074303L (no) | 7-{4-[2-(2,6-diklor-4-metylfenoksy)etoksy]fenyl}-3,9-diazabisyklo-[3.3.1]non-6-en-6-karboksylsyresyklopropyl-(2,3-dimetylbenzyl)amid som renininhibitor til behandling av hypertensjon | |
NO20065456L (no) | Substituerte morfolinforbindelser for behandling av sykdommer i sentralnervesystemet | |
NO20076059L (no) | 2,4-Diamino-pyrimidiner anvendt som aurorainhibitorer | |
NO20091620L (no) | Boronsyre og estere som inhibitorer av fettsyreamidhydrolaser | |
NO20092412L (no) | Hydantoinderivater anvendes som MMP-inhibitorer | |
WO2007016392A3 (fr) | Composes de benzothiazole et d'azabenzothiazole utiles en tant qu'inhibiteurs de kinase | |
NO20091590L (no) | Heterocykliske amidforbindelser anvendbare som kinaseinhibitorer | |
EA200701257A1 (ru) | Пирролопиразолы в качестве сильнодействующих ингибиторов киназы | |
WO2006062984A3 (fr) | Inhibiteurs de proteines kinases | |
NO20056192L (no) | Kapaseinhibitorer og anvendelse derav | |
NO20073572L (no) | Nye forbindelser | |
NO20071242L (no) | Triazolpyridinylsulfanylderivater som P38-MAP-kinaseinhibitorer | |
NO20073791L (no) | Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer | |
NO20091626L (no) | MGLUR5-modulatorer | |
IL183373A0 (en) | 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof | |
WO2007032028A8 (fr) | Thiazolinones et oxazolinones et leur utilisation en tant qu'inhibiteurs de ptp1b | |
NO20076448L (no) | Novel piperidine carboxylic acid amide derivatives | |
CO6270285A2 (es) | Derivados de 4-[(4-amino-1, 3, 5-triazin-2-il)amino]-n-arilmetilcicloalquilcarboxamida | |
AR041299A1 (es) | Derivados de pirrolidona como inhibidores de maob | |
NO20064351L (no) | Caspaseinhibitorer og anvendelser derav | |
NO20085212L (no) | Nye pyridinanaloger | |
NO20073571L (no) | Nye hydantoinderivater som metallproteinaseinhibitorer | |
NO20084186L (no) | Nye aminer | |
NO20083738L (no) | Sekundaere aminer som renininhibitorer | |
NO20080394L (no) | N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |